Skip to main content
Top
Published in: The journal of nutrition, health & aging 2/2017

01-02-2017 | Editorial

Frailty – An emerging high impact complication of diabetes requiring specific management approaches

Authors: Alan Sinclair, B. Vellas

Published in: The journal of nutrition, health & aging | Issue 2/2017

Login to get access

Excerpt

Ever since the Frailty model for diabetes was first described (1) a different management approach to older adults with diabetes who develop frailty has been suggested. The European Diabetes Working Party for Older People (EDWPOP) identified frailty as a key priority area for action (2) and published a glucose-lowering algorithm for frail patients with type 2 diabetes. More recently, the international Diabetes Federation (IDF) launched global guidance on the management of diabetes in older adults and made specific recommendations on treatment in those adults who are dependent and frail who depend on others for their diabetes care (3). Other organisations recognise the impact of multimorbidity and frailty in the overall management of older citizens with diabetes (4-6). We are pleased to announce that more considered guidance to this complex area of diabetes management is in development and in mid-2017, an international collaboration consisting of EDWPOP, IAGG-Garn, AMDA, ICFRSR, and an International Group of Experts, will publish a Position Statement in this area* (see list of collaborators at end of article). …
Literature
1.
go back to reference Sinclair AJ. Diabetes in old age—changing concepts in the secondary care arena. J R Coll Physicians Lond 2000;34:240–44.PubMed Sinclair AJ. Diabetes in old age—changing concepts in the secondary care arena. J R Coll Physicians Lond 2000;34:240–44.PubMed
2.
go back to reference Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L, European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines References for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37 (suppl 3): S27–38.CrossRefPubMed Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L, European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines References for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37 (suppl 3): S27–38.CrossRefPubMed
3.
go back to reference Dunning T, Sinclair AJ, Colagiuri S. New IDF Guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract. 2014 Mar;103(3):538–40.CrossRefPubMed Dunning T, Sinclair AJ, Colagiuri S. New IDF Guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract. 2014 Mar;103(3):538–40.CrossRefPubMed
4.
go back to reference Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–79.CrossRefPubMedPubMedCentral Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–79.CrossRefPubMedPubMedCentral
6.
go back to reference Sinclair A, Morley JE, Rodriquez-Manas L, et al. Diabetes mellitus in older people: position statement on behalf of International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts of Diabetes. J Am Med Dir Assoc 2012;13:497–502.CrossRefPubMed Sinclair A, Morley JE, Rodriquez-Manas L, et al. Diabetes mellitus in older people: position statement on behalf of International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts of Diabetes. J Am Med Dir Assoc 2012;13:497–502.CrossRefPubMed
7.
go back to reference Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014 Dec;15(12):853–9CrossRefPubMed Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014 Dec;15(12):853–9CrossRefPubMed
8.
go back to reference Castro-Rodríguez M, Carnicero JA, Garcia-Garcia FJ, Walter S, Morley JE, Rodríguez-Artalejo F, Sinclair AJ, Rodríguez-Mañas L. Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. J Am Med Dir Assoc. 2016 Oct 1;17(10):949–55.CrossRefPubMed Castro-Rodríguez M, Carnicero JA, Garcia-Garcia FJ, Walter S, Morley JE, Rodríguez-Artalejo F, Sinclair AJ, Rodríguez-Mañas L. Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. J Am Med Dir Assoc. 2016 Oct 1;17(10):949–55.CrossRefPubMed
9.
go back to reference Barnett AH, Huisman H, Jones R, von Eynatten M, Patel S, Woerle H-J. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. Lancet 2013; published online Aug 13. http://dx.doi.org/10.1016/S0140-6736(13)61500-7. Barnett AH, Huisman H, Jones R, von Eynatten M, Patel S, Woerle H-J. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. Lancet 2013; published online Aug 13. http://​dx.​doi.​org/​10.​1016/​S0140-6736(13)61500-7.
10.
go back to reference Strain WD, Lukashevich V, Kothny W, Hoellinger MJ, Paldánius PM. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet 2013;382:409–16.CrossRefPubMed Strain WD, Lukashevich V, Kothny W, Hoellinger MJ, Paldánius PM. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet 2013;382:409–16.CrossRefPubMed
11.
go back to reference Sinclair A, Morley J. Frailty and diabetes.. Lancet. 2013 Oct 26;382(9902):1386–7. doi: 10.1016/S0140-6736(13)61676-1. Epub 2013 Aug 13.CrossRefPubMed Sinclair A, Morley J. Frailty and diabetes.. Lancet. 2013 Oct 26;382(9902):1386–7. doi: 10.1016/S0140-6736(13)61676-1. Epub 2013 Aug 13.CrossRefPubMed
12.
go back to reference Sinclair AJ, Rodriguez-Mañas L; Diabetes and Frailty: Two Converging Conditions? Can J Diabetes. 2016 Feb;40(1):77–83CrossRefPubMed Sinclair AJ, Rodriguez-Mañas L; Diabetes and Frailty: Two Converging Conditions? Can J Diabetes. 2016 Feb;40(1):77–83CrossRefPubMed
13.
go back to reference Park SW1, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Cho YW, Newman AB; Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007 Jun;30(6):1507–12. Epub 2007 Mar 15.CrossRefPubMed Park SW1, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Cho YW, Newman AB; Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007 Jun;30(6):1507–12. Epub 2007 Mar 15.CrossRefPubMed
15.
go back to reference Rodríguez-Mañas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, Hardman TC, Sinclair AJ; MID-Frail Consortium. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes—the MID-Frail study: study protocol for a randomised controlled trial. Trials. 2014 Jan 24;15:34CrossRefPubMedPubMedCentral Rodríguez-Mañas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, Hardman TC, Sinclair AJ; MID-Frail Consortium. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes—the MID-Frail study: study protocol for a randomised controlled trial. Trials. 2014 Jan 24;15:34CrossRefPubMedPubMedCentral
Metadata
Title
Frailty – An emerging high impact complication of diabetes requiring specific management approaches
Authors
Alan Sinclair
B. Vellas
Publication date
01-02-2017
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 2/2017
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-017-0868-5

Other articles of this Issue 2/2017

The journal of nutrition, health & aging 2/2017 Go to the issue